Estimated Control Closed Transaction verified ConsumerConsumer HealthcareConsumer Healthcare / OTC PharmaceuticalsOTC Pharmaceuticals
Boehringer Ingelheim Consumer Healthcare business acquired by Sanofi
Sanofi acquired Boehringer Ingelheim Consumer Healthcare business, a Global / Germany consumer healthcare / otc pharmaceuticals brand, on Jun 27, 2016.
Transaction summary
- Target
- Boehringer Ingelheim Consumer Healthcare business
- Acquirer
- Sanofi
- Seller
- Boehringer Ingelheim
- Announced
- 2016-06-27
- Geography
- Global / Germany
- Tags
- ConsumerConsumer HealthcareConsumer Healthcare / OTC PharmaceuticalsOTC Pharmaceuticals
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-06-19
- Latest update
- 2026-06-19
Value and multiples
Price / value
USD 7.3B
Enterprise Value | USD
Basis: Estimated
EV / revenue
4.4x
Period not stated
Basis: FundComb estimate
EV / EBITDA
16.1x
EBITDA basis not stated
Basis: FundComb estimate
Basis
- USD 7.3bn enterprise value is a FundComb estimate. Public sources reviewed confirm the transaction, but do not independently disclose every valuation input.
- EV / revenue: 4.4x.
- Revenue and multiple inputs are not fully disclosed in public transaction materials reviewed; treat the multiple as an estimate.
- EV / EBITDA: 16.1x.
Source summary
No public source summary has been published for this transaction yet.